SciClone Pharmaceuticals (Holdings) (HKSE:06600) 5-Year Dividend Growth Rate : 0.00% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is SciClone Pharmaceuticals (Holdings) 5-Year Dividend Growth Rate?

SciClone Pharmaceuticals (Holdings)'s Dividends per Share for the six months ended in Dec. 2023 was HK$0.00.

During the past 12 months, SciClone Pharmaceuticals (Holdings)'s average Dividends Per Share Growth Rate was 16.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

SciClone Pharmaceuticals (Holdings)'s Dividend Payout Ratio for the six months ended in Dec. 2023 was 0.00. As of today, SciClone Pharmaceuticals (Holdings)'s Dividend Yield % is 2.10%.

Warning Sign:

SciClone Pharmaceuticals (Holdings) Ltd stock dividend yield is close to 2-year low.

For more information regarding to dividend, please check our Dividend Page.

Competitive Comparison of SciClone Pharmaceuticals (Holdings)'s 5-Year Dividend Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, SciClone Pharmaceuticals (Holdings)'s 5-Year Dividend Growth Rate, along with its competitors' market caps and 5-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SciClone Pharmaceuticals (Holdings)'s 5-Year Dividend Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, SciClone Pharmaceuticals (Holdings)'s 5-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where SciClone Pharmaceuticals (Holdings)'s 5-Year Dividend Growth Rate falls into.

SciClone Pharmaceuticals (Holdings) 5-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

SciClone Pharmaceuticals (Holdings) (HKSE:06600) 5-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

SciClone Pharmaceuticals (Holdings)'s Dividend Payout Ratio for the quarter that ended in Dec. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Dec. 2023 )	/	EPS without NRI (Q: Dec. 2023 )
	=	0	/	0.852
	=	0.00

During the past 7 years, the highest Dividend Payout Ratio of SciClone Pharmaceuticals (Holdings) was 0.23. The lowest was 0.20. And the median was 0.22.

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

During the past 7 years, the highest Dividend Yield of SciClone Pharmaceuticals (Holdings) was 3.76%. The lowest was 2.08%. And the median was 3.15%.

Warning Sign:

SciClone Pharmaceuticals (Holdings) Ltd stock dividend yield is close to 2-year low.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SciClone Pharmaceuticals (Holdings) 5-Year Dividend Growth Rate Related Terms

Thank you for viewing the detailed overview of SciClone Pharmaceuticals (Holdings)'s 5-Year Dividend Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

SciClone Pharmaceuticals (Holdings) (HKSE:06600) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » SciClone Pharmaceuticals (Holdings) Ltd (HKSE:06600) » Definitions » 5-Year Dividend Growth Rate

Traded in Other Exchanges

N/A

Address

381 Middle Huaihai Road, 22nd Floor, Central Plaza, Shanghai, CHN

Website

https://www.sciclone.com

SciClone Pharmaceuticals (Holdings) Ltd is a biopharmaceutical company with an integrated platform for product development and commercialization. It strategically focuses on some of the fast-growing therapeutic areas with unmet medical needs in China, primarily including oncology and severe infection. It generated revenue primarily from the sale of Zadaxin to Sinopharm.

Executives

Ubs Group Ag	2201 Interest of corporation controlled by you
Zhao Hong	2101 Beneficial owner
Gl Capital Management Gp Limited
Meng Liang	2201 Interest of corporation controlled by you
Ascendent Silver (cayman) Limited	2501 Other
Ascendent Capital Partners Ii Gp Limited	2201 Interest of corporation controlled by you
Ascendent Capital Partners Ii, Gp, L.p.	2201 Interest of corporation controlled by you
Ascendent Capital Partners Ii, L.p.	2201 Interest of corporation controlled by you
Gl Partners Capital Management Ltd.
Gl China Opportunities Carry Gp Limited
Ocean Falcon Limited	2101 Beneficial owner
Central Huijin Investment Ltd.	2201 Interest of corporation controlled by you
Bank Of China Limited	2201 Interest of corporation controlled by you
Bank Of China Group Investment Limited	2201 Interest of corporation controlled by you
Gl Capital Management Gp Ii B.c I. Ltd

SciClone Pharmaceuticals (Holdings) (HKSE:06600) Headlines

No Headlines